Porche Kay, Reymond Liz, Callaghan John O', Charles Margaret
Palliative Care Unit, Rockhampton Hospital, 2-80 Canning St, Rockhampton, Qld 4700, Australia. Email:
Brisbane South Palliative Care Collaborative, Griffith University School of Medicine, Metro South Palliative Care Service, Metro South Health, Queensland Health, PO Box 4069, Eight Mile Plains, Qld 4113, Australia. Email:
Aust Health Rev. 2014 Feb;38(1):44-50. doi: 10.1071/AH13041.
To explore the practices of members of the Australian and New Zealand Society of Palliative Medicine (ANZSPM) in assessing and treating depression in palliative care patients.
Semistructured questionnaires were forwarded to ANZSPM members in consecutive mail-outs to survey diagnostic and treatment practices for depression.
The response rate was 62.3%. The median prevalence of depression, as perceived by respondents, in the present respondent patient populations was 20% (range 0%-90%); 57.1% of respondents always assessed for depression, whereas 42.9% assessed for depression sometimes. The majority (98.9%) of respondents relied on clinical interviews to assess depression; non-somatic symptoms of the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV) criteria were more useful than somatic symptoms. The depression screening tools most frequently used were one- and two-item questions. Pharmacological and non-pharmacological methods were used to treat depression, with selective serotonin reuptake inhibitors the most frequently prescribed medications. Psycho-educational and supportive counselling were the most frequently used non-pharmacological interventions. Nominated measures to augment depression management included improving access to psychiatry, psychology and other allied health services, the development of a screening tool specific to palliative care patients and associated guidelines for depression management.
This is the first Australasian study to explore the practice of medical practitioners regarding depression in palliative patients. Incorporation of screening tool questions into palliative care assessment interviews may warrant future research. WHAT IS KNOWN ABOUT THE TOPIC? Depression in palliative care patients has a negative impact on quality of life; however, little is known about how Australasian palliative care medical practitioners manage depression in this patient population. WHAT DOES THIS PAPER ADD? To the researchers' knowledge, this is the first Australasian study that explores the practices of local palliative care specialists in the management of depression in palliative patients. WHAT ARE THE IMPLICATIONS FOR PRACTITIONERS? Overall management of depression in palliative care populations by Australasian practitioners is similar to that of their European colleagues. Consensus is that for assessment of depression in palliative patients, non-somatic symptoms of DSM-IV criteria are more useful than somatic symptoms. Practitioners report the need for improved access to psychiatric, psychological and other support services, for a palliative care-specific depression screening tool and for depression management guidelines applicable to palliative care patients.
探讨澳大利亚和新西兰姑息医学协会(ANZSPM)成员在评估和治疗姑息治疗患者抑郁症方面的实践。
向ANZSPM成员连续邮寄半结构化问卷,以调查抑郁症的诊断和治疗实践。
回复率为62.3%。受访者认为,在当前受访患者群体中,抑郁症的中位患病率为20%(范围0%-90%);57.1%的受访者总是对抑郁症进行评估,而42.9%的受访者有时会评估抑郁症。大多数(98.9%)受访者依靠临床访谈来评估抑郁症;《精神疾病诊断与统计手册》第4版(DSM-IV)标准中的非躯体症状比躯体症状更有用。最常使用的抑郁症筛查工具是单项和两项问题。使用药物和非药物方法治疗抑郁症,选择性5-羟色胺再摄取抑制剂是最常开具的药物。心理教育和支持性咨询是最常使用的非药物干预措施。为加强抑郁症管理而提名的措施包括改善获得精神病学、心理学和其他相关健康服务的机会,开发专门针对姑息治疗患者的筛查工具以及相关的抑郁症管理指南。
这是第一项探索澳大利亚和新西兰地区从业者对姑息治疗患者抑郁症治疗实践的研究。将筛查工具问题纳入姑息治疗评估访谈可能值得未来研究。关于该主题已知的信息是什么?姑息治疗患者的抑郁症对生活质量有负面影响;然而,对于澳大利亚和新西兰的姑息治疗从业者如何管理该患者群体中的抑郁症知之甚少。本文补充了什么?据研究人员所知,这是第一项探索澳大利亚和新西兰地区姑息治疗专家管理姑息治疗患者抑郁症实践情况的研究。对从业者有何启示?澳大利亚和新西兰从业者对姑息治疗人群抑郁症的总体管理与欧洲同行相似。大家一致认为,对于评估姑息治疗患者的抑郁症,DSM-IV标准中的非躯体症状比躯体症状更有用。从业者报告需要改善获得精神科、心理和其他支持服务的机会,需要一种专门针对姑息治疗患者的抑郁症筛查工具以及适用于姑息治疗患者的抑郁症管理指南。